Pancreatic Cancer Research

ResearcherHiroshima University HospitalActive in the last 2 years

Tomoyuki Abe

Matched on ORCID iD 0000-0001-6859-7614; OpenAlex author ID A5054203101. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2017: 2 papers · 2018: 2 papers · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 7

  1. Prognosis prediction for end-stage pancreatic cancer with home medical care: A retrospective cohort study conducted at multiple institutions in Hiroshima. Co-author DOI 10.1186/s12904-026-02015-1↗
  2. Coexistence of Median Arcuate Ligament Syndrome and Pancreatic Ductal Adenocarcinoma: A Case Report on Pancreaticoduodenectomy with Arterial Reconstruction. First author DOI 10.70352/scrj.cr.25-0087↗
  3. Efficacy of the physiobiological parameter-based grading system for predicting the long-term prognosis after curative surgery for resectable pancreatic cancer. Co-author DOI 10.1016/j.ejso.2020.09.008↗
  4. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejso.2018.04.022↗
  5. Prospective Follow-up Study of the Recurrence of Pancreatic Cancer Diagnosed at an Early Stage: The Value of Endoscopic Ultrasonography for Early Diagnosis of … Co-author DOI 10.1097/mpa.0000000000001021↗
  6. Early diagnosis of pancreatic cancer: Current trends and concerns. Last author DOI 10.1002/ags3.12004↗
  7. Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma. Co-author DOI 10.21873/anticanres.12031↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Keiji Hanada · 5 shared papers, 2017–2021 · strength 0.50
  2. Toshio Noriyuki · 3 shared papers, 2017–2021 · strength 0.30
  3. Hiroaki Yamane · 1 shared paper, 2026 · strength 0.26
  4. Noriyoshi Maruyama · 1 shared paper, 2026 · strength 0.26
  5. Kazuhiro Toyota · 1 shared paper, 2025 · strength 0.25
  6. Yuta Hiura · 1 shared paper, 2025 · strength 0.25
  7. Shuji Yonehara · 2 shared papers, 2017–2018 · strength 0.16
  8. Tomoyuki Minami · 2 shared papers, 2017–2018 · strength 0.16
  9. Juri Ikemoto · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.